BIRC5 and familial pancreatic carcinoma: In view of the observed expression pattern of survivin during GEM exposure, further studies should be required to clarify the molecular mechanisms of the possible involvement of RUNX2/survivin pro-oncogenic pathway in the genesis and/or maintenance of GEM-resistant phenotype of pancreatic cancer cells.